Taking an HPV vaccine research-tested intervention to scale in a clinical setting

Suellen Hopfer, Anne E. Ray, Michael L. Hecht, Michelle Miller-Day, Rhonda Belue, Gregory Zimet, W. Douglas Evans, Francis X. McKee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Research tested interventions are seldom ready for wide spread use. Successful intervention adaptation to clinical settings demands an iterative process with target audience feedback. We describe the adaptation process of implementing an NCI research tested HPV vaccine intervention, Women's Stories, to a community clinic context (Planned Parenthood). Five phases are described for the adaptation of content and the development of a health kiosk intervention delivery system: (a) informant interviews with the target audience of young adult, predominantly African-American women, (b) translating HPV vaccine decision narratives into prevention messages, (c) health kiosk interface design, (d) conducting a usability study of the health kiosk intervention product, and (e) conducting a waiting room observational study. Lessons learned and challenges in adapting prevention interventions to clinical settings are discussed.

Original languageEnglish (US)
Pages (from-to)745-752
Number of pages8
JournalTranslational Behavioral Medicine
Volume8
Issue number5
DOIs
StatePublished - Sep 8 2018
Externally publishedYes

Fingerprint

Papillomavirus Vaccines
Health
Research
African Americans
Observational Studies
Young Adult
Interviews

Keywords

  • Adapting an Intervention
  • African American
  • Decision Narratives
  • Dissemination
  • Health Equity
  • HPV vaccine
  • Implementation

ASJC Scopus subject areas

  • Applied Psychology
  • Behavioral Neuroscience

Cite this

Hopfer, S., Ray, A. E., Hecht, M. L., Miller-Day, M., Belue, R., Zimet, G., ... McKee, F. X. (2018). Taking an HPV vaccine research-tested intervention to scale in a clinical setting. Translational Behavioral Medicine, 8(5), 745-752. https://doi.org/10.1093/tbm/ibx066

Taking an HPV vaccine research-tested intervention to scale in a clinical setting. / Hopfer, Suellen; Ray, Anne E.; Hecht, Michael L.; Miller-Day, Michelle; Belue, Rhonda; Zimet, Gregory; Evans, W. Douglas; McKee, Francis X.

In: Translational Behavioral Medicine, Vol. 8, No. 5, 08.09.2018, p. 745-752.

Research output: Contribution to journalArticle

Hopfer, S, Ray, AE, Hecht, ML, Miller-Day, M, Belue, R, Zimet, G, Evans, WD & McKee, FX 2018, 'Taking an HPV vaccine research-tested intervention to scale in a clinical setting', Translational Behavioral Medicine, vol. 8, no. 5, pp. 745-752. https://doi.org/10.1093/tbm/ibx066
Hopfer, Suellen ; Ray, Anne E. ; Hecht, Michael L. ; Miller-Day, Michelle ; Belue, Rhonda ; Zimet, Gregory ; Evans, W. Douglas ; McKee, Francis X. / Taking an HPV vaccine research-tested intervention to scale in a clinical setting. In: Translational Behavioral Medicine. 2018 ; Vol. 8, No. 5. pp. 745-752.
@article{f7e1ed79628245b0a5276f10827f2198,
title = "Taking an HPV vaccine research-tested intervention to scale in a clinical setting",
abstract = "Research tested interventions are seldom ready for wide spread use. Successful intervention adaptation to clinical settings demands an iterative process with target audience feedback. We describe the adaptation process of implementing an NCI research tested HPV vaccine intervention, Women's Stories, to a community clinic context (Planned Parenthood). Five phases are described for the adaptation of content and the development of a health kiosk intervention delivery system: (a) informant interviews with the target audience of young adult, predominantly African-American women, (b) translating HPV vaccine decision narratives into prevention messages, (c) health kiosk interface design, (d) conducting a usability study of the health kiosk intervention product, and (e) conducting a waiting room observational study. Lessons learned and challenges in adapting prevention interventions to clinical settings are discussed.",
keywords = "Adapting an Intervention, African American, Decision Narratives, Dissemination, Health Equity, HPV vaccine, Implementation",
author = "Suellen Hopfer and Ray, {Anne E.} and Hecht, {Michael L.} and Michelle Miller-Day and Rhonda Belue and Gregory Zimet and Evans, {W. Douglas} and McKee, {Francis X.}",
year = "2018",
month = "9",
day = "8",
doi = "10.1093/tbm/ibx066",
language = "English (US)",
volume = "8",
pages = "745--752",
journal = "Translational Behavioral Medicine",
issn = "1869-6716",
publisher = "Springer Publishing Company",
number = "5",

}

TY - JOUR

T1 - Taking an HPV vaccine research-tested intervention to scale in a clinical setting

AU - Hopfer, Suellen

AU - Ray, Anne E.

AU - Hecht, Michael L.

AU - Miller-Day, Michelle

AU - Belue, Rhonda

AU - Zimet, Gregory

AU - Evans, W. Douglas

AU - McKee, Francis X.

PY - 2018/9/8

Y1 - 2018/9/8

N2 - Research tested interventions are seldom ready for wide spread use. Successful intervention adaptation to clinical settings demands an iterative process with target audience feedback. We describe the adaptation process of implementing an NCI research tested HPV vaccine intervention, Women's Stories, to a community clinic context (Planned Parenthood). Five phases are described for the adaptation of content and the development of a health kiosk intervention delivery system: (a) informant interviews with the target audience of young adult, predominantly African-American women, (b) translating HPV vaccine decision narratives into prevention messages, (c) health kiosk interface design, (d) conducting a usability study of the health kiosk intervention product, and (e) conducting a waiting room observational study. Lessons learned and challenges in adapting prevention interventions to clinical settings are discussed.

AB - Research tested interventions are seldom ready for wide spread use. Successful intervention adaptation to clinical settings demands an iterative process with target audience feedback. We describe the adaptation process of implementing an NCI research tested HPV vaccine intervention, Women's Stories, to a community clinic context (Planned Parenthood). Five phases are described for the adaptation of content and the development of a health kiosk intervention delivery system: (a) informant interviews with the target audience of young adult, predominantly African-American women, (b) translating HPV vaccine decision narratives into prevention messages, (c) health kiosk interface design, (d) conducting a usability study of the health kiosk intervention product, and (e) conducting a waiting room observational study. Lessons learned and challenges in adapting prevention interventions to clinical settings are discussed.

KW - Adapting an Intervention

KW - African American

KW - Decision Narratives

KW - Dissemination

KW - Health Equity

KW - HPV vaccine

KW - Implementation

UR - http://www.scopus.com/inward/record.url?scp=85054153066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054153066&partnerID=8YFLogxK

U2 - 10.1093/tbm/ibx066

DO - 10.1093/tbm/ibx066

M3 - Article

C2 - 29425333

AN - SCOPUS:85054153066

VL - 8

SP - 745

EP - 752

JO - Translational Behavioral Medicine

JF - Translational Behavioral Medicine

SN - 1869-6716

IS - 5

ER -